<p>Wesbanco Bank Inc. 在最近向美国证券交易委员会提交的 13F 文件中表示，在第四季度减少了对 GRAIL, Inc. (NASDAQ:GRAL - 免费报告) 的持股比例，减少幅度为 73.0%。该基金在季度内出售了 32,500 股后，持有该公司 12,000 股股票。Wesbanco Bank Inc. 在 GRAIL 的持股在最近的报告期末价值为 1,027,000 美元。</p>
<ul>
<li>小型股亮点：这 3 只股票在 2025 年上涨超过 300%</li>
</ul>
<p>其他一些大型投资者最近也买卖了该股票的股份。Farallon Capital Management LLC 在第三季度将其在 GRAIL 的持股比例提高了 168.7%。Farallon Capital Management LLC 目前持有 1,349,000 股该公司的股票，价值 79,766,000 美元，在此期间又购买了 847,000 股。美国银行（Bank of America Corp DE）在第三季度将其在 GRAIL 的持股比例提高了 121.0%。美国银行（Bank of America Corp DE）目前持有 335,365 股该公司的股票，价值 19,830,000 美元，在此期间又购买了 183,611 股。安联资产管理（Allianz Asset Management GmbH）在第三季度将其在 GRAIL 的持股比例提高了 145.9%。安联资产管理（Allianz Asset Management GmbH）目前持有 294,835 股该公司的股票，价值 17,434,000 美元，在此期间又购买了 174,959 股。先锋集团（Vanguard Group Inc.）在第四季度将其在 GRAIL 的持股比例提高了 9.0%。先锋集团（Vanguard Group Inc.）目前持有 1,980,783 股该公司的股票，价值 169,535,000 美元，在此期间又购买了 163,790 股。最后，景顺（Invesco Ltd.）在第二季度将其在 GRAIL 的持股比例提高了 259.1%。景顺（Invesco Ltd.）目前持有 218,671 股该公司的股票，价值 11,244,000 美元，在此期间又购买了 157,780 股。</p>
<h2>内部人员买卖</h2>
<p>在相关消息中，总裁 Joshua J. Ofman 于 4 月 8 日星期三出售了 61,665 股该股票。股票的平均售价为 49.92 美元，总价值为 3,078,316.80 美元。交易完成后，总裁直接持有 371,216 股该公司的股票，估计价值约为 18,531,102.72 美元。这笔交易代表其持股比例减少了 14.25%。该出售在向美国证券交易委员会的文件中披露，相关信息可通过美国证券交易委员会网站访问。此外，首席财务官 Aaron Freidin 于 4 月 8 日星期三出售了 45,806 股该股票。股票的平均售价为 49.92 美元，总价值为 2,286,635.52 美元。出售完成后，首席财务官持有 260,669 股该公司的股票，估计价值约为 13,012,596.48 美元。这代表其持股比例减少了 14.95%。该出售的披露信息可在美国证券交易委员会的文件中找到。在过去的九十天里，内部人员已出售 310,267 股公司股票，价值 15,485,396 美元。当前公司内部人员持有 1.83% 的股票。</p>
<h2>分析师评级调整</h2>
<ul>
<li>为什么 GRAIL 股票可能成为生物科技的下一个重大突破</li>
</ul>
<p>一些券商对 GRAL 进行了评估。华尔街禅（Wall Street Zen）在周六的研究报告中将 GRAIL 的评级从 “卖出” 上调至 “持有”。瑞穗（Mizuho）在 4 月 10 日星期五的研究报告中开始对 GRAIL 进行覆盖。他们对该股票设定了 “中性” 评级和 58.00 美元的目标价。派珀·桑德勒（Piper Sandler）在周三的研究报告中将 GRAIL 的目标价从 54.00 美元上调至 56.00 美元，并给予该股票 “中性” 评级。韦斯评级（Weiss Ratings）在 4 月 21 日星期二的研究报告中重新发布了对 GRAIL 股票的 “卖出（d-）” 评级。最后，TD Cowen 在周三的研究报告中将 GRAIL 的目标价从 65.00 美元上调至 69.00 美元，并给予该股票 “买入” 评级。四位研究分析师对该股票给予了买入评级，三位给予了持有评级，一位对该公司的股票给予了卖出评级。根据 MarketBeat 的数据，GRAIL 目前的共识评级为 “持有”，共识目标价为 67.88 美元。</p>
<p><strong>获取我们对 GRAL 的最新分析</strong></p>
<h2>GRAIL 股票表现</h2>
<ul>
<li>2025 年表现优异的 3 只医疗技术股票</li>
</ul>
<p>GRAL 股票在周一开盘价为 61.64 美元。该公司的市值为 26.5 亿美元，市盈率为 -5.94，贝塔系数为 3.03。该股票的 50 日简单移动平均线为 51.05 美元，200 日简单移动平均线为 78.44 美元。GRAIL, Inc. 的 12 个月低点为 29.95 美元，12 个月高点为 118.84 美元。</p>
<p>GRAIL (NASDAQ:GRAL - 获取免费报告) 最近在 5 月 5 日星期二发布了其财报。该公司报告本季度每股收益为 -2.29 美元，超过了市场共识预期的 -2.76 美元，超出幅度为 0.47 美元。该业务本季度的收入为 4079 万美元，而分析师预期为 3916 万美元。GRAIL 的股本回报率为 -16.42%，净利润率为 -253.22%。卖方分析师预测 GRAIL, Inc. 本年度每股收益将为 -11.09 美元。</p>
<h2>GRAIL 公司简介</h2>
<p>(免费报告)</p>
<p>GRAIL, Inc NASDAQ: GRAL 是一家生物技术公司，致力于通过多癌症血液检测实现癌症的早期检测。GRAIL 利用下一代测序、游离 DNA (cfDNA) 分析和机器学习的进步，开发了 Galleri™ 测试，旨在在癌症的早期阶段识别超过 50 种癌症。该公司的平台分析循环肿瘤 DNA 中的甲基化模式，以确定肿瘤的存在及其来源组织，使医生能够进行及时的诊断跟进。</p>
<p>GRAIL 于 2016 年作为 Illumina 的一个分拆公司成立，总部位于加利福尼亚州门洛帕克，并在英国设有额外的研究和运营中心。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 GRAIL 更好</li>
<li>三家对数据中心和人工智能运营至关重要的公司</li>
<li>超越 NVIDIA：强劲势头的人工智能相关投资</li>
<li>量子财报季正在升温——关注两大主要参与者</li>
<li>Flutter 在财报后看到提振，FanDuel 显示复苏迹象</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R1JBTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R1JBTA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 到 GRAIL 吗？</h2>
<p>在考虑 GRAIL 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场意识到之前……而 GRAIL 并不在名单上。</p>
<p>虽然 GRAIL 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

GRAL

标普生物技术 3 倍做多 - Direxion

基因改革 ETF - ARK

生物科技 ETF - VanEck Vectors

医药突破 ETF - ALPS

纽交所高增长板生物技术指数 ETF - First Trust

纳斯达克生物科技指数 ETF - iShares Nasdaq

动态生物技术与基因组 ETF - Invesco

2 倍做多纳斯达克生物技术 ETF - ProShares

基因免疫&健康关怀 ETF - iShares

<p>Wesbanco Bank Inc. 在第四季度将其在 GRAIL, Inc. (NASDAQ:GRAL) 的持股减少了 73%，目前持有 12,000 股，之前出售了 32,500 股。其他投资者如 Farallon Capital 和美国银行显著增加了他们的持股。内部人士的销售包括总裁 Joshua J. Ofman 和首席财务官 Aaron Freidin，他们以约 49.92 美元的价格出售了股票。分析师对 GRAIL 的评级各不相同，普遍评级为 “持有”，目标价格为 67.88 美元。GRAIL 股票开盘价为 61.64 美元，市值为 26.5 亿美元，12 个月的价格区间为 29.95 美元至 118.84 美元</p>

<p>Wesbanco Bank Inc. lessened its stake in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 73.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,000 shares of the company's stock after selling 32,500 shares during the quarter. Wesbanco Bank Inc.'s holdings in GRAIL were worth $1,027,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Wesbanco Bank Inc. 在最近向美国证券交易委员会提交的 13F 文件中表示，在第四季度减少了对 GRAIL, Inc. (NASDAQ:GRAL - 免费报告) 的持股比例，减少幅度为 73.0%。该基金在季度内出售了 32,500 股后，持有该公司 12,000 股股票。Wesbanco Bank Inc. 在 GRAIL 的持股在最近的报告期末价值为 1,027,000 美元。</p>
</div><ul>
<li>Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>小型股亮点：这 3 只股票在 2025 年上涨超过 300%</li>
</ul>
</div><p>A number of other large investors have also recently bought and sold shares of the stock. Farallon Capital Management LLC lifted its stake in shares of GRAIL by 168.7% during the 3rd quarter. Farallon Capital Management LLC now owns 1,349,000 shares of the company's stock worth $79,766,000 after purchasing an additional 847,000 shares during the period. Bank of America Corp DE lifted its stake in shares of GRAIL by 121.0% during the 3rd quarter. Bank of America Corp DE now owns 335,365 shares of the company's stock worth $19,830,000 after purchasing an additional 183,611 shares during the period. Allianz Asset Management GmbH lifted its stake in shares of GRAIL by 145.9% during the 3rd quarter. Allianz Asset Management GmbH now owns 294,835 shares of the company's stock worth $17,434,000 after purchasing an additional 174,959 shares during the period. Vanguard Group Inc. lifted its stake in shares of GRAIL by 9.0% during the 4th quarter. Vanguard Group Inc. now owns 1,980,783 shares of the company's stock worth $169,535,000 after purchasing an additional 163,790 shares during the period. Finally, Invesco Ltd. lifted its stake in shares of GRAIL by 259.1% during the 2nd quarter. Invesco Ltd. now owns 218,671 shares of the company's stock worth $11,244,000 after purchasing an additional 157,780 shares during the period.</p>
<div class="lb-trans"><p>其他一些大型投资者最近也买卖了该股票的股份。Farallon Capital Management LLC 在第三季度将其在 GRAIL 的持股比例提高了 168.7%。Farallon Capital Management LLC 目前持有 1,349,000 股该公司的股票，价值 79,766,000 美元，在此期间又购买了 847,000 股。美国银行（Bank of America Corp DE）在第三季度将其在 GRAIL 的持股比例提高了 121.0%。美国银行（Bank of America Corp DE）目前持有 335,365 股该公司的股票，价值 19,830,000 美元，在此期间又购买了 183,611 股。安联资产管理（Allianz Asset Management GmbH）在第三季度将其在 GRAIL 的持股比例提高了 145.9%。安联资产管理（Allianz Asset Management GmbH）目前持有 294,835 股该公司的股票，价值 17,434,000 美元，在此期间又购买了 174,959 股。先锋集团（Vanguard Group Inc.）在第四季度将其在 GRAIL 的持股比例提高了 9.0%。先锋集团（Vanguard Group Inc.）目前持有 1,980,783 股该公司的股票，价值 169,535,000 美元，在此期间又购买了 163,790 股。最后，景顺（Invesco Ltd.）在第二季度将其在 GRAIL 的持股比例提高了 259.1%。景顺（Invesco Ltd.）目前持有 218,671 股该公司的股票，价值 11,244,000 美元，在此期间又购买了 157,780 股。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人员买卖</h2>
</div><p>In related news, President Joshua J. Ofman sold 61,665 shares of the stock in a transaction on Wednesday, April 8th. The stock was sold at an average price of $49.92, for a total value of $3,078,316.80. Following the transaction, the president directly owned 371,216 shares of the company's stock, valued at approximately $18,531,102.72. This trade represents a 14.25% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Aaron Freidin sold 45,806 shares of the stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $49.92, for a total value of $2,286,635.52. Following the completion of the sale, the chief financial officer owned 260,669 shares of the company's stock, valued at approximately $13,012,596.48. This represents a 14.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 310,267 shares of company stock valued at $15,485,396. 1.83% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，总裁 Joshua J. Ofman 于 4 月 8 日星期三出售了 61,665 股该股票。股票的平均售价为 49.92 美元，总价值为 3,078,316.80 美元。交易完成后，总裁直接持有 371,216 股该公司的股票，估计价值约为 18,531,102.72 美元。这笔交易代表其持股比例减少了 14.25%。该出售在向美国证券交易委员会的文件中披露，相关信息可通过美国证券交易委员会网站访问。此外，首席财务官 Aaron Freidin 于 4 月 8 日星期三出售了 45,806 股该股票。股票的平均售价为 49.92 美元，总价值为 2,286,635.52 美元。出售完成后，首席财务官持有 260,669 股该公司的股票，估计价值约为 13,012,596.48 美元。这代表其持股比例减少了 14.95%。该出售的披露信息可在美国证券交易委员会的文件中找到。在过去的九十天里，内部人员已出售 310,267 股公司股票，价值 15,485,396 美元。当前公司内部人员持有 1.83% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><ul>
<li>Why GRAIL Stock Could Be Biotech’s Next Big Breakout</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么 GRAIL 股票可能成为生物科技的下一个重大突破</li>
</ul>
</div><p>A number of brokerages have weighed in on GRAL. Wall Street Zen raised GRAIL from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a research note on Saturday. Mizuho began coverage on GRAIL in a research note on Friday, April 10th. They set a &#34;neutral&#34; rating and a $58.00 price target on the stock. Piper Sandler increased their price target on GRAIL from $54.00 to $56.00 and gave the stock a &#34;neutral&#34; rating in a research note on Wednesday. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of GRAIL in a research note on Tuesday, April 21st. Finally, TD Cowen increased their target price on GRAIL from $65.00 to $69.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, GRAIL presently has a consensus rating of &#34;Hold&#34; and a consensus target price of $67.88.</p>
<div class="lb-trans"><p>一些券商对 GRAL 进行了评估。华尔街禅（Wall Street Zen）在周六的研究报告中将 GRAIL 的评级从 “卖出” 上调至 “持有”。瑞穗（Mizuho）在 4 月 10 日星期五的研究报告中开始对 GRAIL 进行覆盖。他们对该股票设定了 “中性” 评级和 58.00 美元的目标价。派珀·桑德勒（Piper Sandler）在周三的研究报告中将 GRAIL 的目标价从 54.00 美元上调至 56.00 美元，并给予该股票 “中性” 评级。韦斯评级（Weiss Ratings）在 4 月 21 日星期二的研究报告中重新发布了对 GRAIL 股票的 “卖出（d-）” 评级。最后，TD Cowen 在周三的研究报告中将 GRAIL 的目标价从 65.00 美元上调至 69.00 美元，并给予该股票 “买入” 评级。四位研究分析师对该股票给予了买入评级，三位给予了持有评级，一位对该公司的股票给予了卖出评级。根据 MarketBeat 的数据，GRAIL 目前的共识评级为 “持有”，共识目标价为 67.88 美元。</p>
</div><p><strong>Get Our Latest Analysis on GRAL</strong></p>
<div class="lb-trans"><p><strong>获取我们对 GRAL 的最新分析</strong></p>
</div><h2>GRAIL Stock Performance</h2>
<div class="lb-trans"><h2>GRAIL 股票表现</h2>
</div><ul>
<li>3 Medical Technology Stocks Outperforming in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>2025 年表现优异的 3 只医疗技术股票</li>
</ul>
</div><p>Shares of GRAL opened at $61.64 on Monday. The firm has a market capitalization of $2.65 billion, a P/E ratio of -5.94 and a beta of 3.03. The stock's fifty day simple moving average is $51.05 and its 200 day simple moving average is $78.44. GRAIL, Inc. has a twelve month low of $29.95 and a twelve month high of $118.84.</p>
<div class="lb-trans"><p>GRAL 股票在周一开盘价为 61.64 美元。该公司的市值为 26.5 亿美元，市盈率为 -5.94，贝塔系数为 3.03。该股票的 50 日简单移动平均线为 51.05 美元，200 日简单移动平均线为 78.44 美元。GRAIL, Inc. 的 12 个月低点为 29.95 美元，12 个月高点为 118.84 美元。</p>
</div><p>GRAIL (NASDAQ:GRAL - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported ($2.29) earnings per share for the quarter, topping the consensus estimate of ($2.76) by $0.47. The business had revenue of $40.79 million for the quarter, compared to analyst estimates of $39.16 million. GRAIL had a negative return on equity of 16.42% and a negative net margin of 253.22%. Sell-side analysts predict that GRAIL, Inc. will post -11.09 earnings per share for the current year.</p>
<div class="lb-trans"><p>GRAIL (NASDAQ:GRAL - 获取免费报告) 最近在 5 月 5 日星期二发布了其财报。该公司报告本季度每股收益为 -2.29 美元，超过了市场共识预期的 -2.76 美元，超出幅度为 0.47 美元。该业务本季度的收入为 4079 万美元，而分析师预期为 3916 万美元。GRAIL 的股本回报率为 -16.42%，净利润率为 -253.22%。卖方分析师预测 GRAIL, Inc. 本年度每股收益将为 -11.09 美元。</p>
</div><h2>GRAIL Profile</h2>
<div class="lb-trans"><h2>GRAIL 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>GRAIL, Inc NASDAQ: GRAL is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company's platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.</p>
<div class="lb-trans"><p>GRAIL, Inc NASDAQ: GRAL 是一家生物技术公司，致力于通过多癌症血液检测实现癌症的早期检测。GRAIL 利用下一代测序、游离 DNA (cfDNA) 分析和机器学习的进步，开发了 Galleri™ 测试，旨在在癌症的早期阶段识别超过 50 种癌症。该公司的平台分析循环肿瘤 DNA 中的甲基化模式，以确定肿瘤的存在及其来源组织，使医生能够进行及时的诊断跟进。</p>
</div><p>Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.</p>
<div class="lb-trans"><p>GRAIL 于 2016 年作为 Illumina 的一个分拆公司成立，总部位于加利福尼亚州门洛帕克，并在英国设有额外的研究和运营中心。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than GRAIL</li>
<li>3 Companies Quietly Essential to Data Center and AI Operations</li>
<li>Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum</li>
<li>Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players</li>
<li>Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 GRAIL 更好</li>
<li>三家对数据中心和人工智能运营至关重要的公司</li>
<li>超越 NVIDIA：强劲势头的人工智能相关投资</li>
<li>量子财报季正在升温——关注两大主要参与者</li>
<li>Flutter 在财报后看到提振，FanDuel 显示复苏迹象</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R1JBTA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=GRAL"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in GRAIL Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 到 GRAIL 吗？</h2>
</div><p>Before you consider GRAIL, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 GRAIL 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GRAIL wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场意识到之前……而 GRAIL 并不在名单上。</p>
</div><p>While GRAIL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 GRAIL 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

GRAIL, Inc. $GRAL Shares Sold by Wesbanco Bank Inc.

Market Beat

GRAIL

WesBanco

Annaly资本管理

Sculptor Capital

Sun Capital Management Corp.

Nano Labs

美国银行

安联保险集团

安联集团(ADR)

Allianz Technology Trust PLC

The Vanguard Group, Inc.

AMPLITECH GROUP INC. C/WTS 19/02/2026(TO PUR COM)

景顺投资管理

Zensho Holdings Co., Ltd.

金融街

Charter Hall Long WALE REIT

瑞穗金融集团

Mizuho Financial Group, Inc.

Piper Sandler Cos

Weis Markets

卡尔蔡司

NEUBERGER BERMAN REAL ES-W/I

Toronto Dominion Bank

蒙特利尔银行

加拿大帝国商业银行

Wesbanco Pref Shares 7.375 WSBC Perp 10/01/30

ANNALY CAPITAL MANAGEMENT INC 6.95% FXD FLTG CUM RED PFD SR F 30/09/22

ANNALY CAPITAL MANAGEMENT INC 8.875 CUM PREF SER J

ANNALY CAPITAL MANAGEMENT INC 6.750% FXD TO FTG RATE CUM RED PRF SR I

ANNALY CAPITAL MANAGEMENT INC 6.50 CUM RED PFD STK FIX FLT SER G USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

AmpliTech

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Charter Hall Retail REIT

Charter Hall Group

Charter Hall Social Infrastructure REIT

Wesbanco Bank Inc. 出售了 GRAIL, Inc. 的 $GRAL 股票